Joseph P Slattery
CIK 1246530 · EVP and CFO · last filed 2026-06-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TRXC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
635 DAVIS DRIVE, SUITE 300
MORRISVILLE, NC 27560
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMA | Director | 16,000 | $4.05 | $64.8K | $95.8K | 3 | 2026-06-18 |
| CVRX | Director | 39,365 | $1.45 | $57.1K | $71.7K | 14 | 2026-06-03 |
| REPL | Director | 11,867 | $12.47 | $148.0K | -$139.2K | 10 | 2026-04-07 |
| Morphic Holding, Inc. (MORF) Delisted | Director | 9,066 | $56.99 | $516.7K | $149.4K | 8 | 2024-06-05 |
| ASENSUS SURGICAL, INC. (TRXC) Delisted | EVP and CFO | 9,615 | $4.08 | $39.2K | -$7.95M | 28 | 2019-05-15 |
| BAXANO SURGICAL, INC. (BAXS) Delisted | Executive V.P. and CFO | 229,571 | — | — | $0 | 1 | 2013-06-04 |
| BAXANO SURGICAL, INC. (TSON) Delisted | Executive V.P. and CFO | 142,994 | — | — | $351.0K | 19 | 2013-03-01 |
| MICROMET, INC. (MITI) Delisted | Director | 0 | — | — | $24.8K | 7 | 2012-03-06 |
Recent Filings · Page 3 of 10
95 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-10 | Morphic Holding, Inc. (MORF) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | CVRX | Grant (A) | — | $0 | EDGAR |
| 2022-04-29 | Morphic Holding, Inc. (MORF) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-05 | REPL | Grant (A) | — | $0 | EDGAR |
| 2022-01-18 | CVRX | Exer (M) | +11,640 | $3.3K | EDGAR |
| 2021-12-02 | CVRX | Exer (M) | +3,000 | $720 | EDGAR |
| 2021-07-02 | CVRX | Grant (A) | +5,555 | $100.0K | EDGAR |
| 2021-07-01 | CVRX | Grant (A) | — | $0 | EDGAR |
| 2021-06-17 | Morphic Holding, Inc. (MORF) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-05 | REPL | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.